Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serial Response and Biomarker-Guided Steroid Taper for Children With GVHD

NCT05090384 is registered in ClinicalTrials.gov with John Levine as lead sponsor.

NCT NCT05090384
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05090384 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serial Response and Biomarker-Guided Steroid Taper for Children With GVHD
Lead sponsor
John Levine
Phase
Phase 2
Overall status
Completed
Start date
October 20, 2022
Completion date
February 25, 2026
Enrollment
50 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

acute graft vs host disease, adverse effects, allogeneic bone marrow transplantation